Annual report pursuant to Section 13 and 15(d)

Consolidated Income Statements

v3.21.1
Consolidated Income Statements - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Revenue    
Service fees $ 4,778,249 $ 4,167,858
Lease equipment sales 0 74,889
Finance lease revenue 47,707 75,415
Consulting revenue 0 8,310
Total revenue 4,825,956 4,326,472
Cost of sales 3,299,315 3,045,661
Gross profit 1,526,641 1,280,811
Selling, general and administrative expenses 2,600,745 3,026,754
Operating income (loss) (1,074,104) (1,745,943)
Other income and (expense)    
Gain (loss) on investments in securities (14,961) (78,649)
Realized gain on sale of GlauCanna rights 31,000 0
Impairment of investments (139,148) (1,688,825)
Interest income 92,571 108,113
Interest expense (35,295) (22,596)
Gain (loss) on equipment disposal 67 2,200
Paycheck protection program loan forgiven 452,348 0
EIDL grant 10,000 0
Other income (expense) 10,031 21,896
Total other income and (expense) 406,613 (1,657,861)
Income (loss) before provision for income taxes (667,491) (3,403,804)
Provision for income taxes 10,050 14,828
Net Income (Loss) (677,541) (3,418,632)
Gain (loss) attributable to non-controlling interest 48,484 18,258
Net Income (Loss) $ (726,025) $ (3,436,890)
Earnings Per Share, Basic and Diluted    
Earnings Per Share, Basic and Diluted $ (0.032) $ (0.149)
Weighted Average Number of Shares Outstanding, Basic and Diluted 22,850,947 23,117,615